Downregulation of Histone H3.3 Induces p53-Dependent Cellular Senescence in Human Diploid Fibroblasts

Genes (Basel). 2024 Apr 25;15(5):543. doi: 10.3390/genes15050543.

Abstract

Cellular senescence is an irreversible growth arrest that acts as a barrier to cancer initiation and progression. Histone alteration is one of the major events during replicative senescence. However, little is known about the function of H3.3 in cellular senescence. Here we found that the downregulation of H3.3 induced growth suppression with senescence-like phenotypes such as senescence-associated heterochromatin foci (SAHF) and β-galactosidase (SA-β-gal) activity. Furthermore, H3.3 depletion induced senescence-like phenotypes with the p53/p21-depedent pathway. In addition, we identified miR-22-3p, tumor suppressive miRNA, as an upstream regulator of the H3F3B (H3 histone, family 3B) gene which is the histone variant H3.3 and replaces conventional H3 in active genes. Therefore, our results reveal for the first time the molecular mechanisms for cellular senescence which are regulated by H3.3 abundance. Taken together, our studies suggest that H3.3 exerts functional roles in regulating cellular senescence and is a promising target for cancer therapy.

Keywords: aging; histone; microRNA; p53; senescence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cellular Senescence* / drug effects
  • Cellular Senescence* / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Diploidy
  • Down-Regulation
  • Fibroblasts* / physiology
  • HEK293 Cells
  • Heterochromatin / metabolism
  • Histones* / antagonists & inhibitors
  • Histones* / genetics
  • Histones* / metabolism
  • Humans
  • MicroRNAs / metabolism
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Signal Transduction / genetics
  • beta-Galactosidase / metabolism

Substances

  • Histones
  • Heterochromatin
  • beta-Galactosidase
  • MIRN22 microRNA, human
  • MicroRNAs
  • Antineoplastic Agents
  • TP53 protein, human
  • Cyclin-Dependent Kinase Inhibitor p21